SYSTEMIC ANTI-CANCER THERAPY DRUG PATIENT CLINICAL FACTORS DOSE MODIFICATION REASON
The PATIENT clinical factors which resulted in the modification to the Systemic Anti-Cancer Therapy drug dose.
Format / Length
an1
Description
SYSTEMIC ANTI-CANCER THERAPY DRUG PATIENT CLINICAL FACTORS DOSE MODIFICATION REASON is the same as attribute
SYSTEMIC ANTI-CANCER THERAPY DRUG PATIENT CLINICAL FACTORS DOSE MODIFICATION REASON. Record the clinical factors which resulted in a dose modification
National Codes
| Code | Description |
|---|---|
| 1 | Genomics, for example Dihydropyrimidine Dehydrogenase (DPD) enzyme variant |
| 2 | Frailty |
| 3 | Comorbidities |
| 8 | Other (not listed) |
Where Used
| Type | Link | How used |
|---|---|---|
| Data Set | Systemic Anti-Cancer Therapy Data Set | references in description SYSTEMIC ANTI-CANCER THERAPY DRUG PATIENT CLINICAL FACTORS DOSE MODIFICATION REASON |